Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event-Reference-Cited by-同舟云学术

Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event

Published:2023-06 Issue:6 Volume:29 Page:922-930
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

MENTZ ROBERT J.,WARD JONATHAN H.,HERNANDEZ ADRIAN F.,LEPAGE SERGE,MORROW DAVID A.,SARWAT SAMIHA,SHARMA KAVITA,SOLOMON SCOTT D.,STARLING RANDALL C.,VELAZQUEZ ERIC J.,WILLIAMSON KRISTIN,ZIEROTH SHELLEY,BRAUNWALD EUGENE

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial;Solomon;Lancet,2012

2. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction;Solomon;N Engl J Med,2019

3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

4. The vulnerable phase after hospitalization for heart failure;Greene;Nat Rev Cardiol,2015

5. Prior heart failure hospitalization, clinical outcomes, and response to sacubitril/valsartan compared with valsartan in HFpEF;Vaduganathan;J Am Coll Cardiol,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF;JACC: Advances;2024-06

2. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial;Journal of Cardiac Failure;2024-05

3. Representativeness of the PIONEER‐HF and PARAGLIDE‐HF in patients hospitalized with acute heart failure;ESC Heart Failure;2024-04-18

4. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure;Journal of the American College of Cardiology;2024-03

5. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon;Journal of Clinical Medicine;2024-02-28